Microbot Medical Inc (MBOT)

Currency in USD
2.180
-0.010(-0.46%)
Closed·
2.1800.000(0.00%)
·
MBOT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.1352.220
52 wk Range
0.9904.670
Key Statistics
Prev. Close
2.18
Open
2.15
Day's Range
2.135-2.22
52 wk Range
0.99-4.67
Volume
1.07M
Average Volume (3m)
2.77M
1-Year Change
124.72%
Book Value / Share
1.21
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MBOT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
8.750
Upside
+301.38%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Microbot Medical Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Buy

Microbot Medical Inc Company Profile

Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts

Compare MBOT to Peers and Sector

Metrics to compare
MBOT
Peers
Sector
Relationship
P/E Ratio
−11.2x−3.2x−0.6x
PEG Ratio
−0.220.070.00
Price/Book
1.9x4.0x2.6x
Price / LTM Sales
-3.6x3.2x
Upside (Analyst Target)
301.4%51.9%41.8%
Fair Value Upside
Unlock20.5%5.1%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 8.750
(+301.38% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Roth/MKM
Buy5.50+152.29%-New CoverageDec 03, 2025
H.C. Wainwright
Buy12.00+450.46%-MaintainNov 28, 2025
H.C. Wainwright
Buy12.00+450.46%-MaintainNov 21, 2025
H.C. Wainwright
Buy12.00+450.46%-MaintainOct 15, 2025
H.C. Wainwright
Buy12.00+450.46%-MaintainOct 02, 2025

Earnings

Latest Release
Nov 07, 2025
EPS / Forecast
-0.07 / -0.08
Revenue / Forecast
-- / 1.00M
EPS Revisions
Last 90 days

MBOT Income Statement

People Also Watch

5.040
QCLS
-7.35%
2.740
BEAT
-6.48%
0.625
BKYI
-0.79%
0.9179
KITT
+2.67%
1.6500
SIDU
-27.95%

FAQ

What Is the Microbot Medical (MBOT) Stock Price Today?

The Microbot Medical stock price today is 2.180

What Stock Exchange Does Microbot Medical Trade On?

Microbot Medical is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Microbot Medical?

The stock symbol for Microbot Medical is "MBOT."

What Is the Microbot Medical Market Cap?

As of today, Microbot Medical market cap is 146.40M.

What Is Microbot Medical's Earnings Per Share (TTM)?

The Microbot Medical EPS (TTM) is -0.39.

When Is the Next Microbot Medical Earnings Date?

Microbot Medical will release its next earnings report on Feb 25, 2026.

From a Technical Analysis Perspective, Is MBOT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Microbot Medical Stock Split?

Microbot Medical has split 4 times.

How Many Employees Does Microbot Medical Have?

Microbot Medical has 20 employees.

What is the current trading status of Microbot Medical (MBOT)?

As of Dec 24, 2025, Microbot Medical (MBOT) is trading at a price of 2.180, with a previous close of 2.180. The stock has fluctuated within a day range of 2.135 to 2.220, while its 52-week range spans from 0.990 to 4.670.

What Is Microbot Medical (MBOT) Price Target According to Analysts?

The average 12-month price target for Microbot Medical is USD8.75, with a high estimate of USD12 and a low estimate of USD5.5. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +301.38% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.